Correlation Between Affimed NV and Calithera Biosciences
Can any of the company-specific risk be diversified away by investing in both Affimed NV and Calithera Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Affimed NV and Calithera Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Affimed NV and Calithera Biosciences, you can compare the effects of market volatilities on Affimed NV and Calithera Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Affimed NV with a short position of Calithera Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Affimed NV and Calithera Biosciences.
Diversification Opportunities for Affimed NV and Calithera Biosciences
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Affimed and Calithera is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Affimed NV and Calithera Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Calithera Biosciences and Affimed NV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Affimed NV are associated (or correlated) with Calithera Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Calithera Biosciences has no effect on the direction of Affimed NV i.e., Affimed NV and Calithera Biosciences go up and down completely randomly.
Pair Corralation between Affimed NV and Calithera Biosciences
If you would invest (100.00) in Calithera Biosciences on November 29, 2024 and sell it today you would earn a total of 100.00 from holding Calithera Biosciences or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Affimed NV vs. Calithera Biosciences
Performance |
Timeline |
Affimed NV |
Calithera Biosciences |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Affimed NV and Calithera Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Affimed NV and Calithera Biosciences
The main advantage of trading using opposite Affimed NV and Calithera Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Affimed NV position performs unexpectedly, Calithera Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Calithera Biosciences will offset losses from the drop in Calithera Biosciences' long position.Affimed NV vs. ADC Therapeutics SA | Affimed NV vs. Agenus Inc | Affimed NV vs. X4 Pharmaceuticals | Affimed NV vs. Terns Pharmaceuticals |
Calithera Biosciences vs. Abeona Therapeutics | Calithera Biosciences vs. Affimed NV | Calithera Biosciences vs. Checkpoint Therapeutics | Calithera Biosciences vs. Adaptimmune Therapeutics Plc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Commodity Directory Find actively traded commodities issued by global exchanges |